Influenza vaccination among healthy employees: A cost-benefit analysis

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 2, 1997, Pages 181-185

  Kumpulainen, Virpi ^a   Mäkelä, Marjukka ^b  

^a Helsinki City Health Centre   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ABSENTEEISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; HUMAN EXPERIMENT; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; NORMAL HUMAN; OCCUPATIONAL HEALTH; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

EID: 0031005962     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709035881     Document Type: Article

References (21)

1. Immunisation against infectious disease. London: HMSO, 96, 1992.
2. Influenzavaccination 1995/96. EPI-NYT. Sundhedsslyrelsens meldesystem for smittsomme sygdomme, Uge 39, 1995. Statens Seruminstitut, Denmark 1995.
3. Hovi T, Honkanen P, Kuronen T. ja Kansanterveyslaitoksen rokotussuositustyöryhmä. Influenssarokotusten käytöstä syksyllä 1996. Suom Lääkäril 51: 2101-2102, 1996.
4. Influenzavaccination 1995. Recommendations by the Director General of Public Health, Iceland, 1995.
5. Influensavaksine til risikogrupperne 1995/96. MSIS-Rapport, Norway, Uke 34/1995.
6. Om influensa och vaccination. Dnr. 33-7662/94, Socialstyrelsen, Smittskyddssektionen, Folkhälsoenheten, Sweden 1994.
7. Nicholson KG, Snacken R, Palache AM. Influenza immunization policies in Europe and the United States. Vaccine 13: 365-369, 1995.
8. Macnair A. The Case for Comprehensive Immunization Programmes. Influenza Monitoring and Information Bureau, Bucks, 25, 1991.
9. Schoenbaum SC. Economic impact of influenza: the individual's perspective. Am J Med 82: Suppl 6A: 26-30, 1987.
10. Sulander P, Karvonen P, Jokinen M. Influenssarokotuksen vaikutus työstäpoissaoloihin. Suom Lääkäril 32: 537-539, 1977.
11. Smith JWG, Pollard R. Vaccination against influenza: a five-year study in the Post Office. J Hyg Camb 83: 157-170, 1979.
12. Weingarten S, Staniloff H, Ault M, Miles P, Bamberger M, Myer RD. Do hospital employees benefit from the influenza vaccine? J Gen Intern Med 3: 32-37, 1988.
13. Levy E, Levy P. La vaccination contre la grippe des personnes d'âge actif (25-64 ans): une étude coût-bénéfice. Rev Epidém et Santé Publ 40: 285-295, 1992.
14. Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M. The effectiveness of vaccination against influenza in healthy, working adults. New Engl J Med 333: 889-893, 1995.
15. Helliwell BE, Drummond MF. The costs and benefits of preventing influenza in Ontario's elderly. Can J Publ Health 79: 175-180, 1988.
16. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 153: 2105-2111, 1993.
17. Nichol KL, Margolis KL, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New Engl J Med 331: 778-784, 1994.
18. Govaert TME, Thijis CTMCN, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272: 1661-1665, 1994.
19. Pyhälä R, Kleemola M, Kumpulainen V, Vartiainen E, Lappi S, Pönkä A, Cantell K. Immune response to inactivated influenza virus vaccine: antibody reactivity with epidemic influenza B viruses of two highly distinct evolutionary lineages. Vaccine 10: 631-636, 1992.
20. Influenza in Finland. 22nd May 1991. Bulletin of the National Public Health Institute, Finland.
21. Kekki P, Kupiainen O. Lääkärilakko. University of Helsinki, Department of Primary Care, Publications no. 2, 1985.